Position in LLY
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$29,459,202
+$7,152,021 QoQ
Shares Held
24,561
+1.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
2.21%
of 13F equity value
Holder Rank
#728
of 4,605 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026F/m Investments LLC holds $52,996,280 across 11 Drug Manufacturers - General names. LLY ranks #1 (55.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
24,561 | $29,459,202 | |
| 2 | JNJ |
Johnson & Johnson
|
39,177 | $9,949,782 | |
| 3 | ABBV |
AbbVie Inc.
|
24,521 | $6,170,464 | |
| 4 | AMGN |
Amgen Inc
|
4,809 | $1,741,435 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,103 | $1,388,814 | |
| 6 | PFE |
Pfizer Inc
|
47,630 | $1,146,930 | |
| 7 | MRK |
Merck & Co., Inc.
|
7,674 | $986,109 | |
| 8 | GSK |
GSK plc
|
15,772 | $826,768 |
All Filings in LLY
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $29,459,202 | 24,561 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $22,307,181 | 24,253 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $40,298,354 | 37,498 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $29,290,044 | 38,388 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $28,733,475 | 36,860 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $30,400,095 | 36,808 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $28,951,544 | 37,502 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $40,027,654 | 45,181 | Shares | Defined | 2024-10-29 | |
| 2024-06-30 | $43,015,508 | 47,511 | Shares | Defined | 2024-07-29 | |
| No filing history on record for this holder in this stock. | ||||||